Press "Enter" to skip to content

New patent expiration for Acadia Pharms drug NUPLAZID

1
Copyright © DrugPatentWatch. Originally published at New patent expiration for Acadia Pharms drug NUPLAZID

Annual Drug Patent Expirations for NUPLAZID
Annual Drug Patent Expirations for NUPLAZID

Nuplazid is a drug marketed by Acadia Pharms Inc and is included in two NDAs. It is available from one supplier. There are nineteen patents protecting this drug.

Drug patent litigation for NUPLAZID.

This drug has one hundred and thirty-three patent family members in twenty-seven countries.

The generic ingredient in NUPLAZID is pimavanserin tartrate. One supplier is listed for this compound. Additional details are available on the pimavanserin tartrate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Acadia Pharms drug NUPLAZID

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions